iFAST Diagnostics

About iFAST Diagnostics

iFAST Diagnostics is a biotechnology company focused on innovating rapid antimicrobial susceptibility testing. By significantly reducing the time needed for testing from traditional 48-72 hours to just a fraction, iFAST aims to ensure accurate antibiotic prescriptions for patients with bacterial infections. The company leverages advanced technology to provide cost-effective solutions in the diagnostics market, targeting the $4 billion antimicrobial testing sector with plans to launch their product by the end of next year.